Crossmark

Evaluating the effectiveness of advanced platelet-rich fibrin, photobiomodulation, pentoxifylline, and Alveogyl in the treatment of alveolar osteitis: a randomized controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s12903-024-05372-6

Published Online: 2024-12-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yuzbasioglu, Alper

Eroglu, Cennet Neslihan
License Information

Text and Data Mining valid from 2024-12-26

Version of Record valid from 2024-12-26
More Information

Article History

Received: 26 September 2024

Accepted: 20 December 2024

First Online: 26 December 2024

Declarations

:

: The study was based on the approval of the Clinical Studies Ethics Committee of the Faculty of Medicine of Akdeniz University (KAEK 21.09.2022/253–26.04.2023/155), the Turkish Medicines and Medical Devices Agency (30.05.2023/1120566). The written consent obtained from all of the participants was informed.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below